Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Clin Cancer Res. 2011 Dec 5;18(3):869–881. doi: 10.1158/1078-0432.CCR-11-2188

Table 1.

Changes in ALDH1A1, CD44 and CD133 staining from primary to persistent ovarian tumor

Patient ALDH1A1* CD44* CD133*
502
505 NM NM
510
511
522 NC NC
525
535
540 NC NC
544 NM NM
548
549 NC
*

An increase or decrease more than 2-fold designated by arrow NC - Density of cells did not change by more than 2-fold NM - Not measured due to insufficient tumor

HHS Vulnerability Disclosure